Hydroxyurea remains effective over the long term among children with sickle cell disease, real-world data suggested. The ...

Hydroxyurea remains effective long-term in reducing emergency department visits and hospital days for children living with sickle cell disease (SCD), according to new research published in Blood ...

Hydroxyurea remains effective long-term in reducing emergency department visits and hospital days for children living with ...

PRESS RELEASE AB SCIENCE RECEIVES NOTICE OF ALLOWANCE FOR UNITED STATES PATENT COVERING MASITINIB UNTIL 2040 IN THE TREATMENT OF SICKLE CELL ...

Hydroxyurea remains effective long-term in reducing emergency department visits and hospital days for children living ...

Camp Good Days held its annual “Morning of Gratitude” at the Woodcliff Hotel in Fairport, Saturday. The event celebrates volunteers for their contribution to ...

FLEMING-NEON, Ky. (WYMT) - One Letcher County woman who has spent decades as an advocate for people in the region is being ...

The "Genetic Screening Testing for Reproductive Health Market - A Global and Regional Analysis: Focus on Test Type, Application, Technology, End User, and Country-Level Analysis - Analysis and ...

Avascular necrosis in sickle cell disease can occur due to the impairment of blood supply to the bones, writes columnist.

Thursday mornings at the Brody Outpatient Clinic’s pediatric hematology-oncology practice is given over to children with ...

Pfizer is voluntarily withdrawing its sickle cell disease (SCD) therapy Oxbryta from all world markets after finding an "imbalance" in deaths in its clinical trials programme. It's a blow to the ...